glp-1 companion supplement – StayWell (1) Adequate Vitamin B12 status helps support a healthy mood GLP-1 Companion Bundle

The key findings from this clinical program include significant reductions in body weight and fat mass in treatment groups compared to placebo, preferential loss of abdominal and visceral adipose tissue, no changes in serum IGF-1 levels at any dose tested, no negative effects on glucose metabolism or insulin sensitivity, no significant adverse events related to metabolic or endocrine disruption, and safety profile indistinguishable from placebo for most parameters

The authors of a retrospective study found that antidepressants can reduce the weight-loss effect of GLP-1 receptor agonists

Important Note: Results vary significantly from person to person

Impact of Nutrient Type and Sequence on Glucose Tolerance: Physiological Insights and Therapeutic Implications. Peng, Feng, et al